Polmacoxib/Tramadol Hydrochloride

帕马考昔/盐酸曲马多

Report date: 2024/04/10 20:04:22

Base Information

Drug NamePolmacoxib/Tramadol Hydrochloride
Drug Alias Name帕马考昔+盐酸曲马多Polmacoxib and Tramadol HydrochloridePolmacoxib+Tramadol HydrochlorideCG-650CG-100650
ClassificationSmall molecules
Mechanisms of ActionMu opioid receptor agonistsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Mu opioid receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCrystalgenomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrystalgenomics Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A